These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21467668)

  • 41. [Comparison of different preparation methods of tanshinoneporous silica solid dispersion].
    Jiang YR; Zhang ZH; Ding DM; Chen XY; Su E; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(19):3271-6. PubMed ID: 24422390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combining Nuclear Magnetic Resonance Spectroscopy and Density Functional Theory Calculations to Characterize Carvedilol Polymorphs.
    Rezende CA; San Gil RAS; Borré LB; Pires JR; Vaiss VS; Resende JALC; Leitão AA; De Alencastro RB; Leal KZ
    J Pharm Sci; 2016 Sep; 105(9):2648-2655. PubMed ID: 26372719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
    Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
    Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of a drug delivery system with bimodal pH dependent release of a poorly soluble drug.
    Kovacic B; Vrecer F; Planinsek O
    Pharmazie; 2011 Jun; 66(6):465-6. PubMed ID: 21699090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of low levels of the amorphous phase in crystalline pharmaceutical materials by thermally stimulated current spectrometry.
    Venkatesh GM; Barnett ME; Owusu-Fordjour C; Galop M
    Pharm Res; 2001 Jan; 18(1):98-103. PubMed ID: 11336360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A geometric pore adsorption model for predicting the drug loading capacity of insoluble drugs in mesoporous carbon.
    Gao Y; Zhu W; Liu J; Di D; Chang D; Jiang T; Wang S
    Int J Pharm; 2015 May; 485(1-2):25-30. PubMed ID: 25747453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation and correlation of the physicochemical properties of carvedilol.
    Alves JM; Prado LD; Rocha HV
    Pharm Dev Technol; 2016 Nov; 21(7):856-866. PubMed ID: 26336079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier.
    Godec A; Maver U; Bele M; Planinsek O; Srcic S; Gaberscek M; Jamnik J
    Int J Pharm; 2007 Oct; 343(1-2):131-40. PubMed ID: 17590546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of pore size of FSM-16 on the entrapment of flurbiprofen in mesoporous structures.
    Tozuka Y; Wongmekiat A; Kimura K; Moribe K; Yamamura S; Yamamoto K
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):974-7. PubMed ID: 16079530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A fast and reliable DSC-based method to determine the monomolecular loading capacity of drugs with good glass-forming ability in mesoporous silica.
    Hempel NJ; Brede K; Olesen NE; Genina N; Knopp MM; Löbmann K
    Int J Pharm; 2018 Jun; 544(1):153-157. PubMed ID: 29679750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS; Roy K; Choudhary B; Mahadik KR
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simple method for preparation of porous polyimide film with an ordered surface based on in situ self-assembly of polyamic acid and silica microspheres.
    Wang C; Wang Q; Wang T
    Langmuir; 2010 Dec; 26(23):18357-61. PubMed ID: 21067141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.
    Wegmann M; Parola L; Bertera FM; Taira CA; Cagel M; Buontempo F; Bernabeu E; Höcht C; Chiappetta DA; Moretton MA
    J Pharm Pharmacol; 2017 May; 69(5):544-553. PubMed ID: 27431770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A stand-alone mesoporous crystal structure model from in situ X-ray diffraction: nitrogen adsorption on 3D cagelike mesoporous silica SBA-16.
    Miyasaka K; Hano H; Kubota Y; Lin Y; Ryoo R; Takata M; Kitagawa S; Neimark AV; Terasaki O
    Chemistry; 2012 Aug; 18(33):10300-11. PubMed ID: 22829334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation.
    Liu D; Pan H; He F; Wang X; Li J; Yang X; Pan W
    Int J Nanomedicine; 2015; 10():6425-34. PubMed ID: 26508852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.
    Miriyala N; Ouyang D; Perrie Y; Lowry D; Kirby DJ
    Eur J Pharm Biopharm; 2017 Jun; 115():197-205. PubMed ID: 28284728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-Excipient Interactions in the Solid State: The Role of Different Stress Factors.
    Gressl C; Brunsteiner M; Davis A; Landis M; Pencheva K; Scrivens G; Sluggett GW; Wood GPF; Gruber-Woelfler H; Khinast JG; Paudel A
    Mol Pharm; 2017 Dec; 14(12):4560-4571. PubMed ID: 29058913
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular states of prednisolone dispersed in folded sheet mesoporous silica (FSM-16).
    Nishiwaki A; Watanabe A; Higashi K; Tozuka Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Aug; 378(1-2):17-22. PubMed ID: 19465097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.